Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06455449
PHASE3

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease activity in participants with moderate to severe Idiopathic Inflammatory Myopathies (IIM) \[polymyositis (PM) or dermatomyositis (DM)\] while receiving standard of care (SoC) treatment.

Official title: A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

240

Start Date

2024-06-20

Completion Date

2029-04-09

Last Updated

2026-09-24

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Anifrolumab (blinded)

Anifrolumab treatment delivered subcutaneously, once weekly for 52 weeks

OTHER

Placebo

Matched placebo delivered subcutaneously, once weekly for 52 weeks

COMBINATION_PRODUCT

Anifrolumab (unblinded, open label)

At Week 52, all study participants on anifrolumab or placebo will receive open label anifrolumab once weekly for an additional 52 weeks

Locations (237)

Research Site

Phoenix, Arizona, United States

Research Site

Irvine, California, United States

Research Site

Aurora, Colorado, United States

Research Site

Denver, Colorado, United States

Research Site

New Haven, Connecticut, United States

Research Site

Washington D.C., District of Columbia, United States

Research Site

Boca Raton, Florida, United States

Research Site

Boynton Beach, Florida, United States

Research Site

Gainesville, Florida, United States

Research Site

Margate, Florida, United States

Research Site

Miami, Florida, United States

Research Site

Miami, Florida, United States

Research Site

Orlando, Florida, United States

Research Site

Palm Beach Gardens, Florida, United States

Research Site

Plant City, Florida, United States

Research Site

Atlanta, Georgia, United States

Research Site

Willowbrook, Illinois, United States

Research Site

Fairway, Kansas, United States

Research Site

Baltimore, Maryland, United States

Research Site

Boston, Massachusetts, United States

Research Site

Ann Arbor, Michigan, United States

Research Site

Sterling Heights, Michigan, United States

Research Site

Great Neck, New York, United States

Research Site

Charlotte, North Carolina, United States

Research Site

Charlotte, North Carolina, United States

Research Site

Durham, North Carolina, United States

Research Site

Cleveland, Ohio, United States

Research Site

Middleburg Heights, Ohio, United States

Research Site

Philadelphia, Pennsylvania, United States

Research Site

Pittsburgh, Pennsylvania, United States

Research Site

Charleston, South Carolina, United States

Research Site

Summerville, South Carolina, United States

Research Site

Allen, Texas, United States

Research Site

Amarillo, Texas, United States

Research Site

Austin, Texas, United States

Research Site

Colleyville, Texas, United States

Research Site

El Paso, Texas, United States

Research Site

Galveston, Texas, United States

Research Site

Harlingen, Texas, United States

Research Site

Houston, Texas, United States

Research Site

North Richland Hills, Texas, United States

Research Site

Beckley, West Virginia, United States

Research Site

Milwaukee, Wisconsin, United States

Research Site

Buenos Aires, Argentina

Research Site

CABA, Argentina

Research Site

Ciudad de Buenos Aires, Argentina

Research Site

Quilmes, Argentina

Research Site

San Miguel de Tucumán, Argentina

Research Site

Camperdown, Australia

Research Site

Nedlands, Australia

Research Site

New Lambton, Australia

Research Site

Southport, Australia

Research Site

Woodville South, Australia

Research Site

Graz, Austria

Research Site

Vienna, Austria

Research Site

Ghent, Belgium

Research Site

Leuven, Belgium

Research Site

Merksem, Belgium

Research Site

Joinville, Brazil

Research Site

Juiz de Fora, Brazil

Research Site

Pelotas, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Salvador, Brazil

Research Site

Salvador, Brazil

Research Site

São José do Rio Preto, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

Haskovo, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Plovdiv, Bulgaria

Research Site

Rousse, Bulgaria

Research Site

Sofia, Bulgaria

Research Site

Stara Zagora, Bulgaria

Research Site

Calgary, Alberta, Canada

Research Site

Calgary, Alberta, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Concepción, Chile

Research Site

Las Condes, Chile

Research Site

Osorno, Chile

Research Site

Santiago, Chile

Research Site

Santiago, Chile

Research Site

Santiago, Chile

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Chongqing, China

Research Site

Dongguan, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hengyang, China

Research Site

Jining, China

Research Site

Nanjing, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Shijiazhuang, China

And 137 more locations on ClinicalTrials.gov